| Stage | ARMK | % of rev | CTAS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.1B | 100.00% | $3.0B | 100.00% | ARMK ×1.68 |
| Gross profit | $5.1B | 100.00% | $1.6B | 51.54% | ARMK +48.5pp |
| Operating income | $216M | 4.26% | $712M | 23.62% | CTAS +19.4pp |
| Pre-tax income | $136M | 2.68% | $690M | 22.89% | CTAS +20.2pp |
| Net income | $98M | 1.93% | $552M | 18.31% | CTAS +16.4pp |
| Stage | ARMK | CTAS | Gap · A − B |
|---|---|---|---|
| Revenue | $5.1B100.00% | $3.0B100.00% | ARMK ×1.68 |
| Gross profit | 100.00%$5.1B | 51.54%$1.6B | ARMK +48.5pp |
| Operating income | 4.26%$216M | 23.62%$712M | CTAS +19.4pp |
| Pre-tax income | 2.68%$136M | 22.89%$690M | CTAS +20.2pp |
| Net income |
| 1.93%$98M |
| 18.31%$552M |
| CTAS +16.4pp |